Schedule 13G ownership disclosure

Corcept Therapeutics Inc

Common Stock · CUSIP: 218352102

Event date: 2025-03-31

Filing-level shares
13,349,143.00
Percent of class
12.7%
  • BlackRock, Inc.

    Shares: 13,349,143.00 · Class: 12.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002052113-25-000424
Form type
SCHEDULE 13G/A
Filer
BlackRock, Inc.
CIK
CIK 2012383
Filed
Apr 23, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub